Meng weining - Latest News Update, Information, Photos & Videos on Meng weining at Lokmat Times

Santiago, July 25 Chilean Ministers have met executives from the Chinese company Sinovac over the pharmaceutical firm's plan to create a potential vaccination production site.The group visited a plot of land 28 km north of the city of Antofagasta on Friday, which could be the site of a future production plant for Covid-19 vaccines, the Chilean Ministry of Health said on Saturday.It is estimated that the construction of the plant would be completed by the end of 2022, allowing operation to begin from 2023, said the Ministry, adding it would require an investment of about $60 million, reports Xinhua news agency.The plant could "produce vaccines not only for Chile, but also for the rest of Latin America". Health Minister Enrique Paris said.Sinovac Vice President Meng Weining said that the company had "achieved a production of 4 billion doses (of vaccine) per year"."We have carried out clinical studies in this country, which have reaffirmed the excellence of Chilean medical and scientific teams," Meng added.Currently, Chile has fully vaccinated 78.59 per cent of its target population against Covid-19, equivalent to almost 12 million people.The country has registered 1,607,749 cases and 34,958 deaths from Covid-19 so far.Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Home

City

Latest News

Cricket

LT Premium

National

International

Maharashtra

Opinions

Chhatrapati Sambhajinagar

Nagpur

Entertainment

Photos

Business

Technology

Sports

Lifestyle

Social Viral

Lokmat Games

Health

Lok Sabha Election 2024

Heatwave In India

Mumbai Water Cut

Maharashtra Lok Sabha Election

IPL 2024

Salman Khan

Meng WeiningFOLLOW

Meng weining, Latest News

Politics :Chilean Ministers meet Sinovac executives over potential vax production site

Santiago, July 25 Chilean Ministers have met executives from the Chinese company Sinovac over the pharmaceutical firm's plan ... ...